AGEN Agenus Inc

Price (delayed)

$6.73

Market cap

$304.51M

P/E Ratio

10.04

Dividend/share

N/A

EPS

$0.67

Enterprise value

$514.97M

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 95
Relative Valuation: Rel. Valuation: 91
Relative Profitability: Rel. Profitability: 90

Agenus is a leading immuno-oncology company targeting cancer with a comprehensive pipeline of immunological agents. The company was founded in 1994 with a mission to expand patient populations benefiting from ...

Highlights
The quick ratio has soared by 143% from the previous quarter
AGEN's equity has soared by 62% YoY and by 47% QoQ
AGEN's net income has soared by 188% YoY but it has shrunk by 66% QoQ
The EPS has surged by 134% year-on-year but it has dropped by 75% since the previous quarter

Key stats

What are the main financial stats of AGEN

AGEN stock price

How has the Agenus stock price performed over time
Intraday
-2.04%
1 week
-5.87%
1 month
-3.17%
1 year
55.43%
YTD
114.33%
QTD
-32.23%

Financial performance

How have Agenus's revenue and profit performed over time
Revenue
$133.95M
Gross profit
$133.95M
Operating income
$52.15M
Net income
$30.83M
Gross margin
100%
Net margin
23%
AGEN's net income has soared by 188% YoY but it has shrunk by 66% QoQ
AGEN's operating income has surged by 183% year-on-year and by 45% since the previous quarter
Agenus's net margin has surged by 170% YoY but it has shrunk by 67% QoQ
AGEN's operating margin has soared by 166% YoY and by 44% from the previous quarter

Price vs fundamentals

How does AGEN's price correlate with its fundamentals

Growth

What is Agenus's growth rate over time

Valuation

What is Agenus stock price valuation
P/E
10.04
P/B
N/A
P/S
3.15
EV/EBIT
5.64
EV/EBITDA
5.51
EV/Sales
3.84
The EPS has surged by 134% year-on-year but it has dropped by 75% since the previous quarter
AGEN's equity has soared by 62% YoY and by 47% QoQ
The stock's price to sales (P/S) is 66% more than its last 4 quarters average of 1.9 and 21% more than its 5-year quarterly average of 2.6
Agenus's revenue has increased by 25% YoY

Efficiency

How efficient is Agenus business performance
The return on sales has surged by 194% year-on-year but it has declined by 40% since the previous quarter
Agenus's return on assets has surged by 185% YoY but it has shrunk by 68% QoQ
Agenus's ROIC has plunged by 87% YoY and by 60% from the previous quarter

Dividends

What is AGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AGEN.

Financial health

How did Agenus financials performed over time
AGEN's total assets is 31% lower than its total liabilities
The quick ratio has soared by 143% from the previous quarter
Agenus's current ratio has surged by 115% QoQ and by 55% YoY
The debt to equity has dropped by 80% since the previous quarter
AGEN's equity has soared by 62% YoY and by 47% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.